|
|
|
11-50 employees
View all
|
|
Medical Device
|
|
One Highwood Drive, 300, Tewksbury, MA 01876, US
|
|
Corvia Medical, Inc. is revolutionizing the treatment of heart failure with a novel transcatheter structural heart device. Founded in 2009 and headquartered in Tewksbury, MA, Corvia Medical is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. The Corvia® Atrial Shunt is the world’s first transcatheter device approved by the European Union to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction.
Privately held, the company is backed by Third Rock Ventures, General Catalyst Partners, AccelMed, and Lumira Ventures, Edward Lifesciences and an undisclosed strategic investor. In the United States, the Corvia Atrial Shunt System is an investigational device and not available for commercial distribution or sale.
|
Corvia Medical, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Corvia Medical, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Corvia Medical, Inc. customer service number call here +1 978-654-6123. To contact Corvia Medical, Inc. customer service number in your country click here to find.
George Fazio is the CEO of Corvia Medical, Inc.. To contact George Fazio email at [email protected] or [email protected]. Or you may call 2036710448 or 9547073158
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.